Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells

Clinical trial NCT04361942 · COMPLETED

Trial details

NCT number: NCT04361942
Sponsor: Red de Terapia Celular
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2020-05-01
Primary completion: 2021-10-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.